v3.26.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total Stockholder's Equity
Common Stock
Capital in Excess of Par Value
Cumulative Net Income
Accumulated OCI
Cumulative Distributions
Non-controlling Interests
Total
Balance at beginning of period at Dec. 31, 2024 $ 960,627 $ 455 $ 1,082,764 $ 1,725,435 $ 3,815 $ (1,851,842) $ 92,378 $ 1,053,005
Balance (in shares) at Dec. 31, 2024   45,511            
Equity activity                
Issuance of common stock 8,411 $ 2 8,409         8,411
Issuance of common stock (in shares)   238            
Issuance of restricted stock   $ 1 (1)          
Issuance of restricted stock (in shares)   114            
Common stock cash distributions (27,259)         (27,259)   (27,259)
Stock-based compensation expense 2,253   2,253         2,253
Net income 20,680     20,680     1,541 22,221
Vesting of performance-based stock units   $ 2 (2)          
Vesting of performance-based stock units (in shares)   163            
Fair market valuation adjustment for interest rate swap (910)       (910)     (910)
Cash paid for taxes in lieu of common shares (4,772) $ (1) (4,771)         (4,772)
Cash paid for taxes in lieu of common shares (in shares)   (138)            
Acquisitions of non-controlling interest 2,883   2,883       (4,033) (1,150)
Non-controlling interest distributions             (2,486) (2,486)
Other (11)   (11)         (11)
Balance at end of period at Mar. 31, 2025 961,902 $ 459 1,091,524 1,746,115 2,905 (1,879,101) 87,400 1,049,302
Balance (in shares) at Mar. 31, 2025   45,888            
Balance at beginning of period at Dec. 31, 2024 960,627 $ 455 1,082,764 1,725,435 3,815 (1,851,842) 92,378 1,053,005
Balance (in shares) at Dec. 31, 2024   45,511            
Equity activity                
Net income               38,769
Balance at end of period at Jun. 30, 2025 957,507 $ 461 1,099,049 1,761,207 2,188 (1,905,398) 87,400 1,044,907
Balance (in shares) at Jun. 30, 2025   46,065            
Balance at beginning of period at Mar. 31, 2025 961,902 $ 459 1,091,524 1,746,115 2,905 (1,879,101) 87,400 1,049,302
Balance (in shares) at Mar. 31, 2025   45,888            
Equity activity                
Issuance of common stock 5,169 $ 2 5,167         5,169
Issuance of common stock (in shares)   149            
Issuance of restricted stock (in shares)   21            
Common stock cash distributions (26,297)         (26,297)   (26,297)
Stock-based compensation expense 2,795   2,795         2,795
Net income 15,092     15,092     1,456 16,548
Vesting of performance-based stock units (in shares)   20            
Fair market valuation adjustment for interest rate swap (717)       (717)     (717)
Cash paid for taxes in lieu of common shares (437)   (437)         (437)
Cash paid for taxes in lieu of common shares (in shares)   (13)            
Non-controlling interest distributions             (1,456) (1,456)
Balance at end of period at Jun. 30, 2025 957,507 $ 461 1,099,049 1,761,207 2,188 (1,905,398) 87,400 1,044,907
Balance (in shares) at Jun. 30, 2025   46,065            
Balance at beginning of period at Dec. 31, 2025 1,074,984 $ 485 1,189,846 1,843,407 482 (1,959,236) 87,400 1,162,384
Balance (in shares) at Dec. 31, 2025   48,482            
Equity activity                
Issuance of common stock 43,294 $ 11 43,283         43,294
Issuance of common stock (in shares)   1,146            
Issuance of restricted stock   $ 1 (1)          
Issuance of restricted stock (in shares)   130            
Common stock cash distributions (29,171)         (29,171)   (29,171)
Stock-based compensation expense 2,064   2,064         2,064
Net income 23,593     23,593     1,363 24,956
Vesting of performance-based stock units   $ 2 (2)          
Vesting of performance-based stock units (in shares)   171            
Fair market valuation adjustment for interest rate swap 1,074       1,074     1,074
Cash paid for taxes in lieu of common shares (5,875) $ (1) (5,874)         (5,875)
Cash paid for taxes in lieu of common shares (in shares)   (150)            
Non-controlling interest distributions             (15,688) (15,688)
Other (12)   (12)         (12)
Balance at end of period at Mar. 31, 2026 1,109,951 $ 498 1,229,304 1,867,000 1,556 (1,988,407) 73,075 1,183,026
Balance (in shares) at Mar. 31, 2026   49,779            
Balance at beginning of period at Dec. 31, 2025 1,074,984 $ 485 1,189,846 1,843,407 482 (1,959,236) 87,400 1,162,384
Balance (in shares) at Dec. 31, 2025   48,482            
Equity activity                
Net income               55,771
Balance at end of period at Jun. 30, 2026 1,268,556 $ 539 1,386,159 1,896,637 3,409 (2,018,188) 73,075 1,341,631
Balance (in shares) at Jun. 30, 2026   53,906            
Balance at beginning of period at Mar. 31, 2026 1,109,951 $ 498 1,229,304 1,867,000 1,556 (1,988,407) 73,075 1,183,026
Balance (in shares) at Mar. 31, 2026   49,779            
Equity activity                
Issuance of common stock 154,570 $ 41 154,529         154,570
Issuance of common stock (in shares)   4,112            
Issuance of restricted stock (in shares)   15            
Common stock cash distributions (29,781)         (29,781)   (29,781)
Stock-based compensation expense 2,326   2,326         2,326
Net income 29,637     29,637     1,178 30,815
Fair market valuation adjustment for interest rate swap 1,853       1,853     1,853
Non-controlling interest distributions             (1,178) (1,178)
Balance at end of period at Jun. 30, 2026 $ 1,268,556 $ 539 $ 1,386,159 $ 1,896,637 $ 3,409 $ (2,018,188) $ 73,075 $ 1,341,631
Balance (in shares) at Jun. 30, 2026   53,906